In addition to refining and developing innovative treatments (Dr. Toncred Styblo has been heavily involved in refining oncoplastic breast-conserving surgery for nearly 15 years, and Dr. David Kooby recently completed a multi-center study of the efficacy laparoscopic pancreactomy), ongoing clinical research initiatives include the development of multi-disciplinary databases tracking patient outcomes in pancreatic cancer, liver cancer, melanoma, breast cancers and breast reconstruction.

Current basic science studies include Dr. Lily Yang's examinations of the application of nanotechnology to non-invasive molecular imaging for the early diagnosis and management of breast cancer, targeted therapy for head and neck cancer, and delivery of therapeutic agents. Dr. Yang is also investigating the mechanisms of apoptosis resistance and the feasibility of targeting members of the inhibitor of apoptosis family proteins for induction of specific tumor cell death and sensitization to chemotherapy. Dr. Sheryl Gabram is collaborating with Dr. Charlene Bayer of the Georgia Technology Research Institute on a study examining breath biomarkers in exhaled specimens as a potential tool for breast cancer disease detection and monitoring.